Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness

Aim: To assess radioprotective activity of astaxanthin toward radiation-induced in vitro cytogenetic effects in human peripheral blood lymphocytes (PBL). Materials and Methods: PBL from the cleanup workers exposed to ionizing radiation at high doses in 1986 during accident on Chornobyl nuclear power...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2016
Автори: Kurinnyi, D.A., Rushkovsky, S.R., Dybska, O.B., Dubrovina, G.V., Pilinska, M.A.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/137688
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness / D.А. Кurinnyi, S.R. Rushkovsky, О.B. Dybska, G.V. Dubrovina, M.А. Pilinska // Experimental Oncology. — 2016 — Т. 38, № 4. — С. 280-282. — Бібліогр.: 9 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-137688
record_format dspace
spelling nasplib_isofts_kiev_ua-123456789-1376882025-02-23T19:58:08Z Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness Kurinnyi, D.A. Rushkovsky, S.R. Dybska, O.B. Dubrovina, G.V. Pilinska, M.A. Short communications Aim: To assess radioprotective activity of astaxanthin toward radiation-induced in vitro cytogenetic effects in human peripheral blood lymphocytes (PBL). Materials and Methods: PBL from the cleanup workers exposed to ionizing radiation at high doses in 1986 during accident on Chornobyl nuclear power plant and who were diagnosed with acute radiation sickness of the first and second degrees, were cultured in vitro. Astaxanthin was added into the culture medium at a final concentration of 20.0 µg/ml, prior to γ-irradiation of PBL in vitro at a dose of 1 Gy. The slides of metaphase chromosomes were analyzed. Results: Astaxanthin demonstrated considerable radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cyto radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cytoradioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cytogenetic markers of radiation exposure (dicentrics and centric rings). Conclusion: The data evidence on radioprotective capacity of astaxanthin toward radiation-induced cytogenetic effects in vitro in PBL of liquidators irradiated during Chornobyl nuclear power plant accident. This article is a part of a Special Issue entitled “The Chornobyl Nuclear Accident: Thirty Years After”. 2016 Article Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness / D.А. Кurinnyi, S.R. Rushkovsky, О.B. Dybska, G.V. Dubrovina, M.А. Pilinska // Experimental Oncology. — 2016 — Т. 38, № 4. — С. 280-282. — Бібліогр.: 9 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/137688 en Experimental Oncology application/pdf Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Short communications
Short communications
spellingShingle Short communications
Short communications
Kurinnyi, D.A.
Rushkovsky, S.R.
Dybska, O.B.
Dubrovina, G.V.
Pilinska, M.A.
Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
Experimental Oncology
description Aim: To assess radioprotective activity of astaxanthin toward radiation-induced in vitro cytogenetic effects in human peripheral blood lymphocytes (PBL). Materials and Methods: PBL from the cleanup workers exposed to ionizing radiation at high doses in 1986 during accident on Chornobyl nuclear power plant and who were diagnosed with acute radiation sickness of the first and second degrees, were cultured in vitro. Astaxanthin was added into the culture medium at a final concentration of 20.0 µg/ml, prior to γ-irradiation of PBL in vitro at a dose of 1 Gy. The slides of metaphase chromosomes were analyzed. Results: Astaxanthin demonstrated considerable radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cyto radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cytoradioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cytogenetic markers of radiation exposure (dicentrics and centric rings). Conclusion: The data evidence on radioprotective capacity of astaxanthin toward radiation-induced cytogenetic effects in vitro in PBL of liquidators irradiated during Chornobyl nuclear power plant accident. This article is a part of a Special Issue entitled “The Chornobyl Nuclear Accident: Thirty Years After”.
format Article
author Kurinnyi, D.A.
Rushkovsky, S.R.
Dybska, O.B.
Dubrovina, G.V.
Pilinska, M.A.
author_facet Kurinnyi, D.A.
Rushkovsky, S.R.
Dybska, O.B.
Dubrovina, G.V.
Pilinska, M.A.
author_sort Kurinnyi, D.A.
title Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
title_short Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
title_full Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
title_fullStr Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
title_full_unstemmed Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
title_sort astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2016
topic_facet Short communications
url https://nasplib.isofts.kiev.ua/handle/123456789/137688
citation_txt Astaxanthin modifies clastogenic effects of ionizing radiation in vitro in peripheral blood lymphocytes of the persons recovered from acute radiation sickness / D.А. Кurinnyi, S.R. Rushkovsky, О.B. Dybska, G.V. Dubrovina, M.А. Pilinska // Experimental Oncology. — 2016 — Т. 38, № 4. — С. 280-282. — Бібліогр.: 9 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT kurinnyida astaxanthinmodifiesclastogeniceffectsofionizingradiationinvitroinperipheralbloodlymphocytesofthepersonsrecoveredfromacuteradiationsickness
AT rushkovskysr astaxanthinmodifiesclastogeniceffectsofionizingradiationinvitroinperipheralbloodlymphocytesofthepersonsrecoveredfromacuteradiationsickness
AT dybskaob astaxanthinmodifiesclastogeniceffectsofionizingradiationinvitroinperipheralbloodlymphocytesofthepersonsrecoveredfromacuteradiationsickness
AT dubrovinagv astaxanthinmodifiesclastogeniceffectsofionizingradiationinvitroinperipheralbloodlymphocytesofthepersonsrecoveredfromacuteradiationsickness
AT pilinskama astaxanthinmodifiesclastogeniceffectsofionizingradiationinvitroinperipheralbloodlymphocytesofthepersonsrecoveredfromacuteradiationsickness
first_indexed 2025-11-24T20:27:25Z
last_indexed 2025-11-24T20:27:25Z
_version_ 1849704888544526336
fulltext 280 Experimental Oncology 38, 280–282, 2016 (December) ASTAXANTHIN MODIFIES CLASTOGENIC EFFECTS OF IONIZING RADIATION IN VITRO IN PERIPHERAL BLOOD LYMPHOCYTES OF THE PERSONS RECOVERED FROM ACUTE RADIATION SICKNESS D.А. Кurinnyi1,*, S.R. Rushkovsky2, О.B. Dybska1, G.V. Dubrovina1, M.А. Pilinska1 1State Institution “National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine”, Kyiv 04050, Ukraine 2Institute of Biology and Medicine, Taras Shevchenko Kyiv National University, Kyiv 01601, Ukraine Aim: To assess radioprotective activity of astaxanthin toward radiation-induced in vitro cytogenetic effects in human peripheral blood lymphocytes (PBL). Materials and Methods: PBL from the cleanup workers exposed to ionizing radiation at high doses in 1986 during accident on Chornobyl nuclear power plant and who were diagnosed with acute radiation sickness of the first and second degrees, were cultured in vitro. Astaxanthin was added into the culture medium at a final concentration of 20.0 µg/ml, prior to γ-irradiation of PBL in vitro at a dose of 1 Gy. The slides of metaphase chromosomes were analyzed. Results: Astaxanthin demonstrated considerable radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cyto- radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cyto-radioprotective effect in irradiated PBL manifested in significantly decreased levels of unstable cyto- genetic markers of radiation exposure (dicentrics and centric rings). Conclusion: The data evidence on radioprotective capacity of astaxanthin toward radiation-induced cytogenetic effects in vitro in PBL of liquidators irradiated during Chornobyl nuclear power plant accident. This article is a part of a Special Issue entitled “The Chornobyl Nuclear Accident: Thirty Years After”. Key Words: astaxanthin, human peripheral blood lymphocytes, chromosomal aberrations, γ-irradiation, acute radiation sickness, radioprotective effect. In April 26, 1986 the greatest technological catas­ trophe in human history — the nuclear accident at the Chornobyl nuclear power plant (CNPP) took place. In Ukraine 222,498 persons received the status of li­ quidators of this catastrophe. Among liquidators, who performed emergency work on the fourth power unit and received in the early days of the accident doses from 1 to 12 Gy, 134 cases of acute radiation sickness (ARS) were diagnosed [1]. Exposure of humans to ioni­ zing radiation is manifested primarily by the damage of the cell genome, which is one of the driving forces for various pathologies with a genetic component, including the malignant transformation of cells [2]. Therefore, protection of human genome in persons ex­ posed to ionizing radiation is extremely important task. One of the perspective radioprotectors is astaxan­ thin — a natural carotenoid from xanthophyll group. It has low toxicity, high antiradical and antioxidant acti­ vity, the ability to pass through the cell membrane and reach the genetic apparatus in the cell nucleus [3–6]. However, despite a number of investigations of vari­ ous aspects of biological effects of astaxanthin, its possible radioprotective properties are still unknown. It is widely accepted that the frequency of chromo­ somal aberrations in human peripheral blood lympho­ cytes (PBL) specific for ionizing radiation could serve as the reliable indicator of radiation mutagenesis inten­ sity. So, exactly this criterion was chosen by us to as­ sess possible gene protective properties of astaxan­ thin. Previously we discovered the ability of astaxanthin to decrease radiation­induced level of chromosomal aberrations in somatic cells of conditionally healthy volunteers [7]. In present study, we have evaluated both background (output) frequency and spectrum of chromosomal aberrations in PBL and cytogenetic effects of ionizing radiation in vitro per se and com­ bined with astaxanthin to estimate its radioprotective potential even for persons who recovered from ARS. A voluntary cytogenetic examination (under con­ ditions of informed consent) was performed in two liquidators (V. and B. aged 73 and 76, respectively), in whom ARS of first and second degrees of severity caused by radiation exposure during emergency work at the reactor number four of CNPP was diagnosed in the NRCRM clinic in 1987. Official documented ra­ diation doses (2.0 and 2.8 Gy, respectively) for these persons were established in 1986. Since 1987 both liquidators are disabled persons of group II and have been annually examined and treated in the NRCRM clinic. In the past cytogenetic observations of these persons were performed by us several times — pa­ tient V. in 1996; patient B. in 1987, 1992, and 1997. In 2016 not only background (output) frequency and spectrum of chromosomal aberrations in PBL was defined, but also cytogenetic effect under separate and compatible action of astaxanthin and ionizing radiation in vitro. For cytogenetic studies a conventional classical test system, human PBL cultured for 48 h, was used. Asta­ xanthin (Sigma, USA) was introduced into the culture medium in an optimal concentration of 20.0 µg/ml, defined during our previous studies, at early G0 stage of the first mitotic cycle before beginning the PBL in­ cubation, prior to γ­irradiation using emitter IBL­237C (with the capacity of 2.34 Gy/min) at a dose of 1.0 Gy [7]. The cytogenetic analysis accounted all aberrations of chromatid (single fragments, chromatid exchanges) Submitted: November 23, 2016. *Correspondence: E-mail: kourinniy@gmail.com Abbreviations used: ARS — acute radiation sickness; CNPP — Chor- nobyl nuclear power plant; PBL — peripheral blood lymphocytes. Exp Oncol 2016 38, 4, 280–282 SHORT COMMUNICATION Experimental Oncology 38, 280–282, 2016 (December)38, 280–282, 2016 (December) (December) 281 and chromosome (free double fragments, acentric rings, dicentric and ring chromosomes, abnormal monocentrics) types, which can be recognized on uni­ formly stained slides of metaphase chromosomes [8]. The results of cytogenetic analyses are shown in Ta­ bles 1 and 2. The data presented in Table 1 demonstrate a gradual decline over time of the overall frequency of chromosomal aberrations in the exposed individuals, mainly due to the elimination of specific cytogenetic markers of radiation exposure — as unstable (dicentrics and centric rings) as well as stable (abnormal mono­ centrics) aberrations of chromosome type. However, under the cytogenetic survey in 2016, the tendency for increased level of free acentrics (single and double fragments) was found, which permit to suggest the development of hidden chromosomal instability [9]. For detection of the possible hidden chromosomal instability and comparison of individual radiosensitivity, the radiation in vitro exposure of PBL cultures obtained from surveyed persons was conducted. As seen from the data presented in Table 2, under in vitro irradiation of PBL cultures the elevation of cytogenetic effects up to 25.71 ± 2.61 and 32.56 ± 2.69 aberrations per 100 metaphases in liquidators B. and V., respectively, was revealed. In both persons chromosome types of aberrations were dominant, which is typical for chromosomal mutagenesis under the radiation exposure in G0 phase of mitotic cycle. In the irradiated in vitro cultures the individual frequencies of unstable radiogenic markers (total dicentric and ring chromosomes) increased up to 18.22 ± 2.30 and 22.04 ± 2.38 per 100 metaphases in patients B. and V., respectively. Also, the frequency of chromosome type acentrics increased significantly (total number of double fragments and acentric rings increased up to 5.71 ± 1.38 and 9.20 ± 1.65 per 100 metaphases in liquidators B. and V., respectively). These data may indicate the rise of radiosensitivity in “high­doses liqui­ dators” in delayed terms after irradiation. It should be noted that the data on in vitro tests of liquidator V. with lower official dose and lower ARS degree, indi­ cated his higher radiosensitivity. Results of astaxanthin impact on radiation­induced in vitro cytogenetic effects are presented in Table 2, and showed the significant (p < 0.01) reduction of the total frequency of chromosomal aberrations (from 25.71 ± 2.61 to 15.30 ± 2.09 and from 32.56 ± 2.69 to 18.42 ± 2.12 per 100 metaphases in patients B. and V., respec­ tively) due to significant (p < 0.01) decrease of clas­ sical radiogenic markers (dicentric and ring chromo­ somes) — from 18.22 ± 2.30 to 4.08 ± 1.89 and from 22.04 ± 2.38 to 7.89 ± 1.54 per 100 metaphases in pa­ tients B. and V., respectively. The effectiveness of ra­ dioprotective activity of astaxanthin according to these indicators was ~78% and 64% in patients B. and V., respectively under ~82% in unexposed group of healthy donors. However, almost unchanged (p > 0.05) total frequencies of acentrics (7.49 ± 1.57 vs 9.86 ± 1.73 аnd 9.21 ± 1.65 vs 10.43 ± 1.75 per 100 metaphases in pa­ tients B. and V., accordingly) and appearance of ab­ normal monocentrics in liquidator B. (1.36 ± 0.67 per 100 metaphases) may testify both persistence of hidden chromosomal instability in remote terms after high­dose irradiation and increase of individual radiosensitivity in particular because of multiple X­ray examinations of ARS convalescences for a long time. It should be noted that radioprotective activity of astaxanthin in PBL of persons recovered from ARS is lower than in PBL of healthy persons (total frequency of chromosome type aberrations is 66% vs 43% and 48%, respectively) (see Table 2). These data suggest that activity of the repair systems in post­ARS persons is reduced even in delayed terms following high­dose irradiation. REFERENCES 1. National Report «Thirty years of Chornobyl catastro- phe: Radiological and health effects» [monograph on the Internet]. Kyiv: State Institution «National Research Center for Radiation Medicine of National Academy of Medi- cal Sciences of Ukraine» [cited 2016 Nov 22]. Available from: http://www.nrcrm.gov.ua. Table 1. The dynamics of cytogenetic effects in PBL of persons recovered from ARS at different terms after irradiation Indi- vidual code Year of exami- nation Frequency of aberrant cells, % Chromosomal aberrations, per 100 cells Frequency of chromatid type of aberrations, per 100 cells Frequency of chromosome type of aberrations, per 100 cells Single fragments Exchan- ges Total Double fragments Dicentrics Centric rings Abnormal monocentrics Acentric rings TotalM ± SE М ± m B. 1987 11.50 ± 2.26 14.00 ± 2.45 1.00 0 1.00 3.00 1.50 1.00 6.50 1.00 13.00 1992 5.00 ± 1.61 5.00 ± 1.61 1.00 0 1.00 1.50 0.50 0 2.50 0 4.50 1997 2.00 ± 0.99 2.00 ± 0.99 1.50 0 1.50 0.50 0 0 0 0 0.50 2016 3.67 ± 1.20 3.67 ± 1.20 2.45 0 2.45 1.22 0 0 0 0 1.22 V. 1996 7.50 ± 1.86 8.00 ± 1.92 0.50 0 0.50 0 2.50 0.50 4.50 0 7.50 2016 3.87 ± 1.01 3.87 ± 1.01 1.93 0 1.93 1.66 0.28 0 0 0 1.94 Table 2. Cytogenetic effects in PBL of persons recovered from ARS after γ-irradiation in vitro at a dose of 1 Gy per se and combined with astaxanthin Indi- vidual code Treat- ment Frequency of aberrant cells, % Chromosomal aberrations, per 100 cells Frequency of chromatid type of aberrations, per 100 cells Frequency of chromosome type of aberrations, per 100 cells Single fragments Exchan- ges Total Double fragments Dicentrics Centric rings Abnormal monocentrics Acentric rings TotalМ ± SE М ± m B. Irr 25.0 ± 2.58 25.71 ± 2.61 1.78 0 1.78 5.71 16.43 1.79 0 0 23.93 B. Irr + A 14.62 ± 2.06 15.30 ± 2.09 1.70 0 1.70 8.16 4.08 0 1.36 0 13.60 V. Irr 30.92 ± 2.65 32.56 ± 2.69 1.32 0 1.32 7.89 18.75 3.29 0 1.31 31.24 V. Irr + A 16.44 ± 2.12 18.42 ± 2.22 2.30 0 2.30 7.56 7.24 0.65 0 0.67 16.12 * Irr 22.93 ± 1.19 24.55 ± 1.22 1.54 0 1.54 6.47 12.80 2.76 0.49 0.49 23.02 * Irr + A 7.82 ± 0.72 8.48 ± 0.75 0.72 0 0.72 4.67 2.37 0.43 0.22 0.07 7.76 Note: *unexposed group of comparison (n = 4) [7]; Irr — exposition to γ-irradiation; Irr + A — exposition to γ-irradiation and supplementation with astaxanthin. 282 Experimental Oncology 38, 280–282, 2016 (December) 2. Lengauer C, Kinzler KW, Vogelstein B. Genetic insta- bilities in human cancers. Nature 1998; 396: 643–9. 3. Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 2003; 21: 210–6. 4. Nishida Y, Yamashita E, Miki W. Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system. Carotenoid Sci 2007; 11: 16–20. 5. Kamath BS, Srikanta BM, Dharmesh SM, et al. Ulcer preventive and antioxidative properties of astaxan- thin from Haematococcus pluvialis. Eur J Pharmacol 2008; 590: 387–95. 6. Kurihara H, Koda H, Asami S, et al. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci 2002; 70: 2509–20. 7. Pilinska MA, Кurinnyi DA, Rushkovsky SR, Dyb- ska ОB. The impact of astaxanthin on radiation-induced chro- mosome aberrations in human peripheral blood lymphocytes in vitro. Visn Ukr Soc Genet Select 2016; 14: 52–7 (in Ukrai- nian). 8. Zakharov AF, Benyush VA, Kuleshov NP, Baranows- ka LI. Human Chromosomes: Atlas. М: Medicina, 1982. 263 p. (in Russian). 9. Pilinska MA, Dybsky SS, Dybska OB, et al. Peculiarities of induction and persistence of hidden chromosome instability in peripheral blood lymphocytes of persons occupationally exposed to ionizing radiation. Probl Radiac Med Radiobiol 2014; (19): 321–33. Copyright © Experimental Oncology, 2016